IPP Bureau
RPG Life Sciences posts Q3 FY25 PAT higher at Rs. 34.93 Cr
By IPP Bureau - January 28, 2025
RPG Life Sciences has reported total income of Rs. 176.02 crore during the period ended December 31, 2024
Laurus Labs posts Q3 FY25 consolidated PAT higher at Rs. 92.30 Cr
By IPP Bureau - January 28, 2025
Laurus Labs has reported total income of Rs. 1,424.47 crores during the period ended December 31, 2024
Mankind Pharma launches 45-day healthcare mission at Mahakumbh
By IPP Bureau - January 28, 2025
The camp, operational daily from 12 PM to 4 PM, offers free health check-ups, blood pressure monitoring
Toray develops membrane doubling filtration for biopharmaceutical manufacturing processes
By IPP Bureau - January 28, 2025
The company will initially supply prototypes to diverse customers to evaluate in purification processes for producing gene therapy drugs with a view to swift commercialization
Granules India Q3 FY25 PAT drops 6% to Rs 118 Cr
By IPP Bureau - January 27, 2025
The company said it voluntarily paused production at the Gagillapur plant in September 2024 for risk assessment on account of the USFDA observations
Pfizer’s BRAFTOVI combination demonstrates improved response for mutant metastatic colorectal cancer
By IPP Bureau - January 27, 2025
BRAFTOVI combination regimen is the first and only targeted therapy approvedby the U.S. FDA for treatment-naïve patients with metastatic colorectal cancer with a BRAF V600E mutation
SaponiQx, Probius, and Ginkgo Bioworks to revolutionize vaccine adjuvant development
By IPP Bureau - January 27, 2025
Groundbreaking collaboration harnesses AI-driven insights and advanced manufacturing to create next-generation adjuvants for emerging biological threats
AstraZeneca plans US$ 570 million investment in Canada
By IPP Bureau - January 27, 2025
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies
Cupid gets female condom variant UNFPA prequalified to supply 100% of upcoming South Africa tender
By IPP Bureau - January 25, 2025
Earlier, Cupid Limited had been eligible to supply 75% of the contract for female condoms in previous tenders
Mankind Pharma Q3 FY25 PAT dips 16% to Rs. 385 Cr
By IPP Bureau - January 25, 2025
Q3 FY25 revenue up 24% to Rs 3,230 crore
Merck inaugurates expansion of its Peenya facility in Bengaluru
By IPP Bureau - January 25, 2025
Expansion makes Merck Life Science in Bengaluru a key manufacturing location in the APAC region
Senores Pharmaceuticals reports revenue of Rs. 288 crore in 9M FY25
By IPP Bureau - January 24, 2025
PAT after MI is Rs. 41 crore which is 162% increase
Shilpa Pharma Lifesciences received CEP from EDQM for API, Teriflunomide
By IPP Bureau - January 24, 2025
Teriflunomide is a novel disease-modifying agent that was approved for use in the treatment of multiple sclerosis
Alivus Life Sciences delivers 12% revenue growth
By IPP Bureau - January 24, 2025
EBITDA margins expand to 31.3%
Emcure Pharmaceuticals inaugurates R&D centre in Ahmedabad
By IPP Bureau - January 24, 2025
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
